What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Pres­i­dent-elect Don­ald Trump’s two picks for the Fed­er­al Trade Com­mis­sion are like­ly to ush­er in more life sci­ences deals while main­tain­ing the agency’s pres­sure on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER